Association of p53 Arg72Pro polymorphism with esophageal cancer: A meta-analysis based on 14 case-control studies

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 10, 2013, Pages 721-726

  Zhao, Lanjun ^a   Zhao, Xilong ^b   Wu, Xiaoming ^a   Tang, Wenru ^a  

^a KUNMING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b KUNMING GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

AFRICA; ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; CODON; DNA POLYMORPHISM; ESOPHAGUS CANCER; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; META ANALYSIS (TOPIC); POLYMERASE CHAIN REACTION; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; MALE; MODELS, GENETIC; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884573007     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2013.0103     Document Type: Article

References (49)

1. Bennett WP, Hussain SP, Vahakangas KH, et al. (1999) Molecular epidemiology of human cancer risk: Gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol 187:8-18
2. Bergamaschi D, Samuels Y, Sullivan A, et al. (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38:1133-1141
3. Brady CA, Attardi LD (2010) p53 at a glance. J Cell Sci 123:2527
4. Brosh R, Rotter V (2009) When mutants gain new powers: News from the mutant p53 field. Nat Rev Cancer 9:701-713
5. Cai L, Mu LN, Lu H, et al. (2006) Dietary selenium intake and genetic polymorphisms of the GSTP1 and p53 genes on the risk of esophageal squamous cell carcinoma. Cancer Epidem Biomar 15:294-300
6. Canova C, Hashibe M, Simonato L, et al. (2009) Genetic associations of 115 polymorphisms with cancers of the upper aerodigestive tract across 10 European countries: The ARCAGE project. Cancer Res 69:2956-2965
7. Cao Y, Ge H, Chen L, et al. (2007) Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Chin J Cancer 26:1052
8. Cho Y, Gorina S, Jeffrey PD, et al. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265:346-355
9. DerSimonian R, Laird N (1986) Meta-Analysis in clinical trials. Control Clin Trials 7:177-188
10. Dumont P, Leu JIJ, Della Pietra AC, et al. (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357-365
11. Egger M, Davey Smith G, Schneider M, et al. (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629-634
12. Franceschi S, Bidoli E, Negri E, et al. (2000) Role of macronutrients, vitamins and minerals in the aetiology of squamous-cell carcinoma of the oesophagus. Int J cancer 86:626-631
13. Gao Y, McLaughlin J, Blot W, et al. (1994) Risk factors for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int J cancer 58:192
14. Giaccia AJ, Kastan MB (1998) The complexity of p53 modulation: Emerging patterns from divergent signals. Genes Dev 12:2973-2983
15. Greenblatt MS, Bennett WP, Hollstein M, et al. (1994) Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878
16. Hamajima N, Matsuo K, Suzuki T, et al. (2002) No associations of p73 G4C14-To-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett 181:81-85
17. Hausen H (1996) Papillomavirus infections -A major cause of human cancers. Biochim Biophys Acta 1288:F55-F78
18. Hollstein M, Rice K, Greenblatt M, et al. (1994) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 22:3551
19. Hollstein M, Sidransky D, Vogelstein B, et al. (1991) p53 mutations in human cancers. Science 253:49-53
20. Hong Y, Miao X, Zhang X, et al. (2005) The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Res 65:9582-9587
21. Hu J, Nyrén O, Wolk A, et al. (1994) Risk factors for esophageal cancer in northeast China. Int J cancer 57:38-46
22. Hu N, Li WJ, Su H, et al. (2003) Common genetic variants of TP53 and BRCA2 in esophageal cancer patients and healthy individuals from low and high risk areas of northern China. Cancer Detect Prev 27:132-138
23. Kawajiri K, Nakachi K, Imai K, et al. (1993) Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14:1085-1089
24. Lee JM, Lee YC, Yang SY, et al. (2000) Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 89:458-464
25. Levine AJ, Oren M (2009) The first 30 years of p53: Growing ever more complex. Nat Rev Cancer 9:749-758
26. Li T, Lu ZM, Guo M, et al. (2002) p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-Associated carcinomas in China. Cancer 95:2571-2576
27. Liu G, Cescon DW, Zhai R, et al. (2010) p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. Dis Esophagus 23:36-39
28. Mantel N, HaenszelW(1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
29. Montesano R, Hainaut P (1998) Molecular precursor lesions in oesophageal cancer. Cancer Surv 32:53-68
30. Murata M, Tagawa M, Kimura M, et al. (1996) Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 17:261-264
31. Peixoto Guimaraes D, Hsin Lu S, Snijders P, et al. (2001) Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett 162:231-235
32. Piao JM, Kim HN, Song HR, et al. (2011) p53 codon 72 polymorphism and the risk of esophageal cancer: A Korean casecontrol study. Dis Esophagus 24:596-600
33. Pim D, Banks L (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108:196-199
34. Sakamuro D, Sabbatini P, White E, et al. (1997) The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15:887
35. Shao Y, Tan W, Zhang S (2008) P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: A case/control study in a Chinese population. Dis Esophagus 21:139-143
36. Shi H, Tan SJ, Zhong H, et al. (2009) Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia. Am J Hum Genet 84:534-541
37. Sjalander A, Birgander R, Kivela A, et al. (1995) p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 45:144-149
38. Storey A, Thomas M, Kalita A, et al. (1998) Role of a p53 polymorphism in the development of human papilloma-virusassociated cancer. Nature 393:229-234
39. Sullivan A, Syed N, Gasco M, et al. (2004) Polymorphism in wild-Type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23:3328-3337
40. Thomas M, Kalita A, Labrecque S, et al. (1999) Two polymorphic variants of wild-Type p53 differ biochemically and biologically. Mol Cell Biol 19:1092-1100
41. Vos M, Adams CH, Victor TC, et al. (2003) Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. Cancer Genet Cytogen 140:23-30
42. Walker KK, Levine AJ (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93:15335
43. Wang YC, Chen CY, Chen SK, et al. (1999) p53 codon 72 polymorphism in Taiwanese lung cancer patients: Association with lung cancer susceptibility and prognosis. Clin Cancer Res 5:129-134
44. Weston A, Ling-Cawley HM, Caporaso NE, et al. (1994) Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer. Carcinogenesis 15:583-587
45. Wu Y, Chen J, Ohshima H, et al. (1993) Geographic association between urinary excretion of N-nitroso compounds and oesophageal cancer mortality in China. Int J cancer 54:713-719
46. Xing D, Tan W, Lin D (2003) Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (Review). Oncol Rep 10:1615
47. Yang W, Zhang Y, Tian X, et al. (2008) p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma. Mol Carcinog 47:100-104
48. Zhang JH, Li Y, Wang R, et al. (2003) p53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population (in Chinese). Zhonghua Zhong Liu Za Zhi 25:365-367
49. Zhang L, Xing D, He Z, et al. (2002) p53 gene codon 72 polymorphism and susceptibility to esophageal squamous cell carcinoma in a Chinese population (in Chinese). Chin J Med Genet 19:10